Company News, Patents

Kemin Pharma Patents

Patent No. US 7,098,243 B2: A method of treating an infection caused by herpesvirinae has been patented by Kemin Pharma Europe B.V.B.A., Des Moines, Iowa.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters